Nuclear technology, also known as isotope and radiation technology, has high-tech, high-efficiency, and high-quality characteristics in its related industries. Developing the nuclear technology application industry is an inevitable trend to adapt to the new round of technological revolution and industrial transformation, expand the field of nuclear technology applications, and promote the high-quality development of the nuclear industry
MOREThanks to this great era, we are fortunate to be in the high light of the development of nuclear medicine, ‘knowing the shortcomings and making progress, looking at the distant mountains and moving forward’.
MOREFrom 20 to 22 September 2024, the sixth offline practical training course for medical physicists (nuclear medicine), hosted by the Chinese Association of Ethnic Health, undertaken by the Training Department of the Chinese Association of Ethnic Health and the Nuclear Medicine Branch of the Chinese Association of Ethnic Health, with technical support from the Third Affiliated Hospital of Hebei Medical University and Zhejiang Repair Medical Science and Technology Company Limited, was successfully held in the courtyard of the Third Affiliated Hospital of Hebei Medical University. Successfully held.
MOREFrom 6 to 8 September 2024, Repair Medical's fifth technical seminar was successfully held in Jilin City, Jilin Province, where technical managers and technical support engineers from all regions of the country gathered in the spirit of exploration
MOREFrom June 21 to 23, 2024, the opening ceremony of the Clinical Technical Cooperation support Unit for Medical Physicists (Nuclear medicine) of China National Health Association and the fourth offline practical training course for Medical Physicists (Nuclear medicine) was successfully held in the Third Hospital of Hebei Medical University.
MOREThe State Council Information Office held a regular policy briefing of The State Council at 3 PM on June 14, 2024 (Friday). Li Bin, Deputy Director of the NHC, and officials of the National Medical Insurance Administration, the National Disease Control and Prevention Administration and the National Food and Drug Administration were invited to introduce the Key Tasks of Deepening the Reform of the Medical and Health System in 2024 and answer questions from journalists.
MOREOn May 25, 2024, the "Gansu Nuclear Medicine SPECT/CT Quality Control Training Course" sponsored by the Gansu Nuclear Medicine Professional Quality Control Center was successfully held in the First Hospital of Lanzhou University. Tian Wentao, a senior engineer of Zhejiang Repair Medical Technology Co., Ltd. was invited to participate in the training, and was responsible for guiding the students to carry out practical exercises. The profound and simple teaching content was warmly praised by the students of the training class.
MOREIn order to protect the health of radiation workers, patients and the public, and promote the high-quality development of radiation diagnosis and treatment work, we hereby notify the following matters concerning further radiation monitoring of medical radiation sites in medical institutions.
MOREOn April 22, 2024, CNPC China Tongfu's unit, CNPC Qualcomm, announced that China's first annual output of 10,000 Curie carrier-free Lutetium-177 production line and annual output of 1,000 germanium gallium [68Ge-68Ga] generator production line were fully completed and put into operation
MOREOn April 22, 2024, CNPC China Tongfu's unit, CNPC Qualcomm, announced that China's first annual output of 10,000 Curie carrier-free Lutetium-177 production line and annual output of 1,000 germanium gallium [68Ge-68Ga] generator production line were fully completed and put into operation
MOREIn today's rapidly changing era of science and technology, only continuous learning and continuous training can follow the pace of technological progress and synchronize with the development of nuclear medicine in China.
MORE"Carbon-14 irradiation production targets start piling up!" At 13:48 on April 20, with the order, the carbon-14 target was successfully extracted from the Qinshan Nuclear Power heavy water reactor unit invested and controlled by China Nuclear Power (stock code: 601985), a subsidiary of CNNC Group
MOREOn April 11, according to the announcement of the State Food and Drug Administration, human thyroid-stimulating hormone injection (generic celebrity thyroid-stimulating hormone injection, trade name Zhishujia?) was approved for marketing, and the indication is for the adjuvant treatment of iodine [131I] to remove residual thyroid tissue in patients with differentiated thyroid cancer without distant metastasis after total thyroidectomy or near-total thyroidectomy.
MOREThe number of patients with coronary heart disease in China is 11.39 million, and its incidence rate and mortality rate are increasing year by year. The annual medical expenditure is more than 100 billion yuan.
MORENuclear medicine is an important part of modern medicine, and it plays an irreplaceable role in the early and accurate diagnosis, treatment, efficacy monitoring and individualized treatment of diseases, especially major diseases such as tumors, cardiovascular and central nervous system diseases.
MOREProstate cancer, as the second most common cancer in men, has always been a key research area in the medical community for its diagnosis and treatment.
MORECopyright@2023 Zhejiang Repair Medical Technology Co., LTD All rights reserved ICP:18046259-1